Patents by Inventor Jan-Erling Backvall

Jan-Erling Backvall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210139881
    Abstract: The invention relates to an immobilized protein material comprising a protein that is immobilized on a glass material or organic polymer through affinity tag binding. The glass material may be a porous glass material such as (hybrid) controlled porosity glass. The invention also relates to the use of an immobilized enzyme material as a heterogeneous biocatalyst in chemical synthesis. The invention further relates to a method for the immobilization of affinity tagged proteins on a glass material or organic polymer, and to a method for the purification and isolation of affinity tagged proteins by the immobilization of such proteins on a glass material or organic polymer.
    Type: Application
    Filed: January 19, 2021
    Publication date: May 13, 2021
    Inventors: Karim Engelmark CASSIMJEE, Jan-Erling Bäckvall
  • Patent number: 10793848
    Abstract: The invention relates to an immobilized protein material comprising a protein that is immobilized on a glass material or organic polymer through affinity tag binding. The glass material may be a porous glass material such as (hybrid) controlled porosity glass. The invention also relates to the use of an immobilized enzyme material as a heterogeneous biocatalyst in chemical synthesis. The invention further relates to a method for the immobilization of affinity tagged proteins on a glass material or organic polymer, and to a method for the purification and isolation of affinity tagged proteins by the immobilization of such proteins on a glass material or organic polymer.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: October 6, 2020
    Assignee: ENGINZYME AB
    Inventors: Karim Engelmark Cassimjee, Jan-Erling Bäckvall
  • Publication number: 20190241884
    Abstract: The invention relates to an immobilized protein material comprising a protein that is immobilized on a glass material or organic polymer through affinity tag binding. The glass material may be a porous glass material such as (hybrid) controlled porosity glass. The invention also relates to the use of an immobilized enzyme material as a heterogeneous biocatalyst in chemical synthesis. The invention further relates to a method for the immobilization of affinity tagged proteins on a glass material or organic polymer, and to a method for the purification and isolation of affinity tagged proteins by the immobilization of such proteins on a glass material or organic polymer.
    Type: Application
    Filed: April 15, 2019
    Publication date: August 8, 2019
    Inventors: Karim Engelmark CASSIMJEE, Jan-Erling Bäckvall
  • Patent number: 9981978
    Abstract: There is provided a novel process for the preparation of a compound of formula I, wherein R1, R2 and R3 are as described in the description, by conversion of a corresponding allylic alcohol.
    Type: Grant
    Filed: July 23, 2014
    Date of Patent: May 29, 2018
    Assignee: Cambrex Charles City, Inc.
    Inventors: Michael Tracey, Pär Holmberg, Belén Lindberg Martín Matute, Antonio Bermejo Gómez, Jan-Erling Bäckvall
  • Publication number: 20160340667
    Abstract: The invention relates to an immobilized protein material comprising a protein that is immobilized on a glass material or organic polymer through affmity tag binding. The glass material may be a porous glass material such as (hybrid) controlled porosity glass. The invention also relates to the use of an immobilized enzyme material as a heterogeneous biocatalyst in chemical synthesis. The invention further relates to a method for the immobilization of affmity tagged proteins on a glass material or organic polymer, and to a method for the purification and isolation of affmity tagged proteins by the immobilization of such proteins on a glass material or organic polymer.
    Type: Application
    Filed: January 30, 2015
    Publication date: November 24, 2016
    Inventors: Karim Engelmark CASSIMJEE, Jan-Erling BÄCKVALL
  • Publication number: 20070111973
    Abstract: The present invention refers to steroid derivatives for use as medicaments. More specifically, the invention also relates to the use of a steroid derivative of 5-androstene-, 5-pregnenolone or corresponding saturated derivatives (androstane- or pregnane-) in the manufacture of a medicament for the treatment of a benign and/or malignant tumour, which medicament is capable of interrupting disturbances in Wut-signaling, such as cell-cycle arrest in G1-phase, and/or providing an angiostatic effect. Examples of such steroid derivatives are -5-androstene-17-ol, androstane-17-ol-pregnane-17-ol or pregnane-17-ol derivatives.
    Type: Application
    Filed: December 12, 2006
    Publication date: May 17, 2007
    Inventors: Tomas Hagstrom, Peter Soderkvist, Jan-Erling Backvall
  • Publication number: 20050192262
    Abstract: The present invention refers to steroid derivatives for use as medicaments. More specifically, the invention also relates to the use of a steroid derivative of 5-androstene-, 5-pregnenolone or corresponding saturated derivatives (androstane- or pregnane-) in the manufacture of a medicament for the treatment of a benign and/or malignant tumour, which medicament is capable of interrupting disturbances in Wnt-signaling, such as cell-cycle arrest in G1-phase, and/or providing an angiostatic effect. Examples of such steroid derivatives are -5-androstene-17-ol, androstane-17-ol-pregnane-17-ol or pregnane-17-ol derivatives.
    Type: Application
    Filed: September 9, 2003
    Publication date: September 1, 2005
    Inventors: Tomas Hagstrom, Peter Soderkvist, Jan-Erling Backvall